DRUG THERAPEUTIC RECORD # __2___
Name E.M Reason for Admission
Age 66 Sex Male Medical Impression
SIDE
DRUG MECHANISM CONTRA- EFFECTS/
DRUG CLASS INDICATIONS NURSING CONSIDERATION
NAME OF ACTION INDICATIONS ADVERSE
EFFECTS
Generic: Therapeutic: Produces Patient’s Contraindicated in: CNS: Before:
Salmeterol + bronchodilators accumulation of Indications: Hypersensitivity; headache, ● Assess lung sounds, pulse,
Fluticasone cyclic Treatment of Acute attack nervousness. and BP before administration
adenosine asthma of asthma (onset of CV: and periodically during therapy.
Pharmacologic: monophosphate action is delayed); palpitations, ● Monitor pulmonary function
Adrenergics (cAMP) at General: Patients not receiving tachycardia. tests before initiating
beta2- As concomitant a long-term asthma- GI: abdominal therapy and periodically during
adrenergic therapy for the control medication pain, diarrhea, therapy.
receptors. treatment of (e.g., nausea. ● Observe for paradoxical
Brand: Relatively asthma and inhaled MS: muscle bronchospasm (wheezing,
Seretide specific for beta the prevention corticosteroid); cramps/sores. dyspnea, tightness in chest) and
(pulmonary) of Patients whose Neuro: hypersensitivity reaction
receptors. bronchospasm asthma is currently trembling. (rash; urticaria; swelling of the
in patients who controlled on low- or Resp: face, lips, or
are medium-dose inhaled ASTHMA- eyelids). Frequently occurs with
currently taking corticosteroid RELATED first use of new canister
but are therapy. DEATH, or vial. If condition occurs,
inadequately Use Cautiously in: paradoxical withhold medication
controlled on a Cardiovascular bronchospasm and notify physician or other
long-term disease (including , cough. health care professional
asthma-control angina and immediately.
medication hypertension); Seizure During:
(e.g., inhaled disorders; Diabetes; ● Salmeterol should be used
corticosteroid). Glaucoma; along with an inhaled
Prevention of Hyperthyroidism; corticosteroid, not as
exercise- Pheochromocytoma; monotherapy. Patients taking
induced Excessive use (may salmeterol twice daily should not
bronchospasm. lead to tolerance and use additional
Maintenance paradoxical doses for exercise-induced
treatment to bronchospasm) bronchospasm.
prevent ● Inhaln: Once removed from foil
bronchospasm overwrap, discard
in chronic diskus when every blister has
obstructive Pregnancy been used or 6 wk
pulmonary Category: have passed, whichever comes
disease C first.
(COPD) ● Do not use a spacer with
including powder for inhalation.
chronic After:
bronchitis and ● Advise patient to take
emphysema. salmeterol as directed. Do not
use more than the prescribed
dose. If a regularly
scheduled dose is missed, use
as soon as possible
and resume regular schedule.
Do not double doses.
If symptoms occur before next
dose is due, use a
rapid-acting inhaled
bronchodilator.
● Instruct patient using powder
for inhalation never
to exhale into diskus device and
always to hold device
in a level horizontal position.
Mouthpiece
should be kept dry; never wash.
● Caution patient not to use
salmeterol to treat acute
symptoms. A rapid-acting
inhaled beta-adrenergic
bronchodilator should be used
for relief of acute
asthma attacks.
● Advise patients on chronic
therapy not to use additional
salmeterol to prevent exercise-
induced bronchospasm.
Patients using salmeterol for
prevention
of exercise-induced
bronchospasm should not use
additional doses of salmeterol